The Global Mice Model Market size was valued at USD 1.5 Billion in 2023 and the total Global Mice Model revenue is expected to grow at a CAGR of 6.8% from 2024 to 2030, reaching nearly USD 2.8 Billion by 2030.Global Mice Model Market Overview:
This growth is fuelled by several factors. Advancements in creating new and improved mice models are making them more relevant for research. The rise of personalized medicine is increasing the demand for these models to test the effectiveness of treatments tailored to individual patients. The increasing pipelines of pharmaceutical and biopharmaceutical companies necessitate more preclinical testing, further driving the mice model market. The market also faces challenges. Ethical concerns surrounding animal testing and regulations aimed at ensuring the ethical use of animals hinder growth. Additionally, the development of alternative testing methods potentially replace the need for mice models in some instances. Despite these challenges, the mice model market is expected to maintain its upward trajectory due to the ongoing need for reliable preclinical testing in various research fields.To know about the Research Methodology:-Request Free Sample Report Advancements in gene editing techniques The emergence of CRISPR gene editing is a game-changer for the mice model market. Earlier, generating mice with specific diseases or mutations was a laborious and error-prone process. This limited the accuracy and reliability of preclinical testing, a critical bottleneck in drug discovery. However, CRISPR offers a much faster, more targeted, and cost-effective approach to manipulating the mouse genome. This translates to mice models that more faithfully mimic human diseases. For instance, scientists now introduce disease-causing mutations with pinpoint accuracy, creating highly relevant models for studying disease progression and potential treatments. The impact goes beyond just mimicking diseases. CRISPR allows for the development of humanized mice by incorporating specific human genes or tissues. This significantly narrows the gap between preclinical testing in mice and human trials, accelerating the entire drug development process. The ease and precision of CRISPR editing streamline the creation of sophisticated and human-relevant mice models. This translates to faster and more reliable preclinical testing, ultimately fuelling the growth of the mice model market. This trend to continue, with increasing demand for these improved models driving Mice Model market growth during the forecast period. The rise of personalized medicine is driving a significant force within the mice model market. The increased need for tailored preclinical testing. Traditionally, drug development relied on a "one-size-fits-all approach, leading to treatments that weren't always effective for everyone. However, personalized medicine focuses on individual patient needs, requiring therapies targeted to specific genetic variations. This shift necessitates a more nuanced approach to preclinical testing. Here's where the mice model market comes in. Mice with precise genetic modifications, mirroring specific patient mutations, is used to evaluate the efficacy and safety of personalized treatments. This allows researchers to test how a drug work for a particular patient population before moving to human trials. The ability to create these highly customized models with CRISPR and other gene editing advancements is a boon for the mice model market. It fosters a more efficient drug development pipeline, with therapies demonstrably effective for specific patient groups reaching human trials faster. This not only benefits pharmaceutical companies but also accelerates the delivery of life-saving treatments to patients in need. As personalized medicine takes centre stage, the ability to create highly specific mice models remain a crucial tool in developing effective therapies for a wider range of patients. Growing pipeline of pharmaceutical and biopharmaceutical companies. The pharmaceutical and biopharmaceutical landscape is experiencing a surge in new drug discovery and development activity, with a continuously growing pipeline of potential treatments. This trend has a significant positive impact on the mice model market. These companies rely heavily on preclinical testing to evaluate the safety and efficacy of potential drugs before human trials commence. As their pipelines increase, the demand for robust and reliable preclinical testing solutions within the mice model market grows in tandem. The mice model market offers a powerful tool for pharmaceutical companies the ability to create disease models in mice that closely mimic human conditions. This allows researchers to assess the potential effectiveness and potential side effects of new drugs in a controlled environment. With a growing number of drug candidates, the need for these in-vivo models within the mice model market becomes ever more crucial. Furthermore, the increasing focus on novel therapies, particularly those targeting specific diseases or patient populations, necessitates even more specialized testing models. The mice model market cater to this demand by providing mice with specific genetic modifications or disease states that mirror the target population. This tailored testing approach allows for a more accurate prediction of a drug's efficacy in humans, ultimately leading to a higher success rate in clinical trials. The increasing pipeline of pharmaceutical and biopharmaceutical companies directly translates to a thriving mice model industry. As the need for preclinical testing solutions grows alongside the development of new drugs, the demand for sophisticated and specialized mice models within the mice model market continue to be a major driver of industry growth.
Global Mice Model Market Segment Analysis
The mice model market is segmented by oncology (cancer), neurology (brain and nervous system), metabolic diseases (like diabetes), immunology (immune system), cardiovascular diseases (heart and blood vessels), and other diseases. In 2023, the oncology segment holds the biggest share of the market. This dominance is driven by the significant increase in research funding dedicated to developing personalized cancer treatments. A prime example is the National Cancer Institute (NCI), which has allocated a substantial portion of its research budget, around USD xx billion, towards various cancer research areas, including brain and central nervous system cancers. This funding directly translates to a higher demand for specialized mice models specifically designed for cancer research. Globally, breast and lung cancers were the most frequently diagnosed in 2020, accounting for 12.5% and 12.2% of all new cancer cases respectively. Colorectal cancer ranked third, with an estimated 1.9 million new cases diagnosed that year, representing 10.7% of global cases.The increasing number of cancer patients creates a ripple effect. It highlights the need for effective treatments, which in turn fuels research using mice models. This drives demand for various types of mice models, ultimately leading to market growth. Based on model types mice model market segmented by Inbred, Outbred and Hybrid. In 2023, inbred mice dominated the market. This dominance is due to their genetic uniformity. Because inbred mice are genetically identical, they offer consistent and reproducible results in research. This makes them ideal for studying complex traits and diseases, where researchers need to control for genetic variations. This advantage has significantly contributed to the growth of the inbred mice segment within the overall mice model market.
Rank Cancer New cases in 2020 1 Breast 2,261,419 2 Lung 2,206,771 3 Colorectal 1,931,590 4 Prostate 1,414,259 5 Stomach 1,089,103 6 Liver 905,677 7 Cervix uteri 604,127 8 Oesophagus 604,100 9 Thyroid 586,202 10 Bladder 573,278 11 Non-Hodgkin lymphoma 544,352 12 Pancreas 495,773 13 Leukaemia 474,519 14 Kidney 431,288 15 Corpus uteri 417,367 16 Lip, oral cavity 377,713 17 Melanoma of skin 324,635 18 Ovary 313,959 19 Brain, central nervous system 308,102 20 Larynx 184,615 
Global Mice Model Market Regional Analysis
North America is poised to be a leader in the mice model market during the forecast period. This growth is fuelled by a confluence of factors. Firstly, healthcare spending in the region is on the rise, which translates to more funding available for research and development. This increased investment directly translates to a greater demand for mice models to study various diseases and develop new treatments. The prevalence of both infectious and non-communicable diseases in North America is a growing concern. These diseases necessitate research using mice models to understand how they work and develop targeted therapies. In addition, the market itself is quite active, with companies collaborating and forming agreements to push the boundaries of research using mice models. This collaborative spirit fosters innovation and fuels market growth within North America.Mice Model Market Scope: Inquire before buying
Global Mice Model Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 1.5 Bn. Forecast Period 2024 to 2030 CAGR: 6.8% Market Size in 2030: US $ 2.8 Bn. Segments Covered: by Model Types Inbred Outbred Hybrid by Therapeutic Area Oncology Neurology Immunology by Application Research Drug Discovery Mice Model Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (razil, Argentina Rest of South America)Global Mice Model Market Key Players:
Global Mice Model Providers in North America: 1. Laboratory Corporation of America Holdings (Burlington, North Carolina, USA) 2. Charles River Laboratories International, Inc. (Wilmington, Massachusetts, USA) 3. The Jackson Laboratory (Bar Harbor, Maine, USA) 4. Taconic Biosciences, Inc. (Germantown, New York, USA) 5. Crown Biosciences (San Diego, California, USA) 6. TransCure bioServices (Montreal, Quebec, Canada) 7. Cyagen Biosciences (Canton, Massachusetts, USA) 8. The Andersons, Inc. (Maumee, Ohio, USA) 9. Allentown, LLC (Allentown, New Jersey, USA)) Global Mice Model Providers in Europe: 10. Envigo (Huntingdon, Cambridgeshire, UK) [Previously known as Harlan Laboratories] 11. Janvier Labs (Yvonné, France) 12. Genoway (Lyon, France) 13. Ingenious Targeting Laboratory (Ghent, Belgium) Global Mice Model Providers in Asia-Pacific: 14. Trans Genic, Inc. (Fukuoka, Japan) 15. Harbour Antibodies Bv (Harbin, China) [Harbour Biomed subsidiary] 16. PolyGene (Beijing, China) 17. GVK BIO (Hyderabad, India) 18. Ozgene Pty Ltd. (Brisbane, Queensland, Australia) FAQs: 1. Which region has the largest share in Global Mice Model Market? Ans: North America region holds the highest share in 2023. 2. What is the growth rate of Global Mice Model Market? Ans: The Global Mice Model Market is growing at a CAGR of 6.8% during forecasting period 2024-2030. 3. What segments are covered in Global Mice Model market? Ans: Global Mice Model Market is segmented into Model Types, Therapeutic Area, Application, and region. 4. Who are the key players in Global Mice Model market? Ans: The important key players in the Global Mice Model Market are – Laboratory Corporation of America Holdings (Burlington, North Carolina, USA), Charles River Laboratories International, Inc. (Wilmington, Massachusetts, USA), The Jackson Laboratory (Bar Harbor, Maine, USA), Taconic Biosciences, Inc. (Germantown, New York, USA), Crown Biosciences (San Diego, California, USA), TransCure bioServices (Montreal, Quebec, Canada), Cyagen Biosciences (Canton, Massachusetts, USA), The Andersons, Inc. (Maumee, Ohio, USA),Allentown, LLC (Allentown, New Jersey, USA)and Others 5. What is the study period of this market? Ans: The Global Mice Model Market is studied from 2023 to 2030.
1. Mice Model Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Mice Model Market: Dynamics 2.1. Mice Model Market Trends by Region 2.1.1. North America Mice Model Market Trends 2.1.2. Europe Mice Model Market Trends 2.1.3. Asia Pacific Mice Model Market Trends 2.1.4. Middle East and Africa Mice Model Market Trends 2.1.5. South America Mice Model Market Trends 2.2. Mice Model Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Mice Model Market Drivers 2.2.1.2. North America Mice Model Market Restraints 2.2.1.3. North America Mice Model Market Opportunities 2.2.1.4. North America Mice Model Market Challenges 2.2.2. Europe 2.2.2.1. Europe Mice Model Market Drivers 2.2.2.2. Europe Mice Model Market Restraints 2.2.2.3. Europe Mice Model Market Opportunities 2.2.2.4. Europe Mice Model Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Mice Model Market Drivers 2.2.3.2. Asia Pacific Mice Model Market Restraints 2.2.3.3. Asia Pacific Mice Model Market Opportunities 2.2.3.4. Asia Pacific Mice Model Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Mice Model Market Drivers 2.2.4.2. Middle East and Africa Mice Model Market Restraints 2.2.4.3. Middle East and Africa Mice Model Market Opportunities 2.2.4.4. Middle East and Africa Mice Model Market Challenges 2.2.5. South America 2.2.5.1. South America Mice Model Market Drivers 2.2.5.2. South America Mice Model Market Restraints 2.2.5.3. South America Mice Model Market Opportunities 2.2.5.4. South America Mice Model Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Mice Model Industry 2.8. Analysis of Government Schemes and Initiatives For Mice Model Industry 2.9. Mice Model Market Trade Analysis 2.10. The Global Pandemic Impact on Mice Model Market 3. Mice Model Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2023-2030 3.1. Mice Model Market Size and Forecast, by Model Types (2023-2030) 3.1.1. Inbred 3.1.2. Outbred 3.1.3. Hybrid 3.2. Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 3.2.1. Oncology 3.2.2. Neurology 3.2.3. Immunology 3.3. Mice Model Market Size and Forecast, by Application (2023-2030) 3.3.1. Research 3.3.2. Drug Discovery 3.4. Mice Model Market Size and Forecast, by Region (2023-2030) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America Mice Model Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 4.1. North America Mice Model Market Size and Forecast, by Model Types (2023-2030) 4.1.1. Inbred 4.1.2. Outbred 4.1.3. Hybrid 4.2. North America Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 4.2.1. Oncology 4.2.2. Neurology 4.2.3. Immunology 4.3. North America Mice Model Market Size and Forecast, by Application (2023-2030) 4.3.1. Research 4.3.2. Drug Discovery 4.4. North America Mice Model Market Size and Forecast, by Country (2023-2030) 4.4.1. United States 4.4.1.1. United States Mice Model Market Size and Forecast, by Model Types (2023-2030) 4.4.1.1.1. Inbred 4.4.1.1.2. Outbred 4.4.1.1.3. Hybrid 4.4.1.2. United States Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 4.4.1.2.1. Oncology 4.4.1.2.2. Neurology 4.4.1.2.3. Immunology 4.4.1.3. United States Mice Model Market Size and Forecast, by Application (2023-2030) 4.4.1.3.1. Research 4.4.1.3.2. Drug Discovery 4.4.2. Canada 4.4.2.1. Canada Mice Model Market Size and Forecast, by Model Types (2023-2030) 4.4.2.1.1. Inbred 4.4.2.1.2. Outbred 4.4.2.1.3. Hybrid 4.4.2.2. Canada Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 4.4.2.2.1. Oncology 4.4.2.2.2. Neurology 4.4.2.2.3. Immunology 4.4.2.3. Canada Mice Model Market Size and Forecast, by Application (2023-2030) 4.4.2.3.1. Research 4.4.2.3.2. Drug Discovery 4.4.3. Mexico 4.4.3.1. Mexico Mice Model Market Size and Forecast, by Model Types (2023-2030) 4.4.3.1.1. Inbred 4.4.3.1.2. Outbred 4.4.3.1.3. Hybrid 4.4.3.2. Mexico Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 4.4.3.2.1. Oncology 4.4.3.2.2. Neurology 4.4.3.2.3. Immunology 4.4.3.3. Mexico Mice Model Market Size and Forecast, by Application (2023-2030) 4.4.3.3.1. Research 4.4.3.3.2. Drug Discovery 5. Europe Mice Model Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 5.1. Europe Mice Model Market Size and Forecast, by Model Types (2023-2030) 5.2. Europe Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 5.3. Europe Mice Model Market Size and Forecast, by Application (2023-2030) 5.4. Europe Mice Model Market Size and Forecast, by Country (2023-2030) 5.4.1. United Kingdom 5.4.1.1. United Kingdom Mice Model Market Size and Forecast, by Model Types (2023-2030) 5.4.1.2. United Kingdom Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 5.4.1.3. United Kingdom Mice Model Market Size and Forecast, by Application (2023-2030) 5.4.2. France 5.4.2.1. France Mice Model Market Size and Forecast, by Model Types (2023-2030) 5.4.2.2. France Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 5.4.2.3. France Mice Model Market Size and Forecast, by Application (2023-2030) 5.4.3. Germany 5.4.3.1. Germany Mice Model Market Size and Forecast, by Model Types (2023-2030) 5.4.3.2. Germany Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 5.4.3.3. Germany Mice Model Market Size and Forecast, by Application (2023-2030) 5.4.4. Italy 5.4.4.1. Italy Mice Model Market Size and Forecast, by Model Types (2023-2030) 5.4.4.2. Italy Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 5.4.4.3. Italy Mice Model Market Size and Forecast, by Application (2023-2030) 5.4.5. Spain 5.4.5.1. Spain Mice Model Market Size and Forecast, by Model Types (2023-2030) 5.4.5.2. Spain Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 5.4.5.3. Spain Mice Model Market Size and Forecast, by Application (2023-2030) 5.4.6. Sweden 5.4.6.1. Sweden Mice Model Market Size and Forecast, by Model Types (2023-2030) 5.4.6.2. Sweden Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 5.4.6.3. Sweden Mice Model Market Size and Forecast, by Application (2023-2030) 5.4.7. Austria 5.4.7.1. Austria Mice Model Market Size and Forecast, by Model Types (2023-2030) 5.4.7.2. Austria Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 5.4.7.3. Austria Mice Model Market Size and Forecast, by Application (2023-2030) 5.4.8. Rest of Europe 5.4.8.1. Rest of Europe Mice Model Market Size and Forecast, by Model Types (2023-2030) 5.4.8.2. Rest of Europe Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 5.4.8.3. Rest of Europe Mice Model Market Size and Forecast, by Application (2023-2030) 6. Asia Pacific Mice Model Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 6.1. Asia Pacific Mice Model Market Size and Forecast, by Model Types (2023-2030) 6.2. Asia Pacific Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 6.3. Asia Pacific Mice Model Market Size and Forecast, by Application (2023-2030) 6.4. Asia Pacific Mice Model Market Size and Forecast, by Country (2023-2030) 6.4.1. China 6.4.1.1. China Mice Model Market Size and Forecast, by Model Types (2023-2030) 6.4.1.2. China Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 6.4.1.3. China Mice Model Market Size and Forecast, by Application (2023-2030) 6.4.2. S Korea 6.4.2.1. S Korea Mice Model Market Size and Forecast, by Model Types (2023-2030) 6.4.2.2. S Korea Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 6.4.2.3. S Korea Mice Model Market Size and Forecast, by Application (2023-2030) 6.4.3. Japan 6.4.3.1. Japan Mice Model Market Size and Forecast, by Model Types (2023-2030) 6.4.3.2. Japan Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 6.4.3.3. Japan Mice Model Market Size and Forecast, by Application (2023-2030) 6.4.4. India 6.4.4.1. India Mice Model Market Size and Forecast, by Model Types (2023-2030) 6.4.4.2. India Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 6.4.4.3. India Mice Model Market Size and Forecast, by Application (2023-2030) 6.4.5. Australia 6.4.5.1. Australia Mice Model Market Size and Forecast, by Model Types (2023-2030) 6.4.5.2. Australia Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 6.4.5.3. Australia Mice Model Market Size and Forecast, by Application (2023-2030) 6.4.6. Indonesia 6.4.6.1. Indonesia Mice Model Market Size and Forecast, by Model Types (2023-2030) 6.4.6.2. Indonesia Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 6.4.6.3. Indonesia Mice Model Market Size and Forecast, by Application (2023-2030) 6.4.7. Malaysia 6.4.7.1. Malaysia Mice Model Market Size and Forecast, by Model Types (2023-2030) 6.4.7.2. Malaysia Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 6.4.7.3. Malaysia Mice Model Market Size and Forecast, by Application (2023-2030) 6.4.8. Vietnam 6.4.8.1. Vietnam Mice Model Market Size and Forecast, by Model Types (2023-2030) 6.4.8.2. Vietnam Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 6.4.8.3. Vietnam Mice Model Market Size and Forecast, by Application (2023-2030) 6.4.9. Taiwan 6.4.9.1. Taiwan Mice Model Market Size and Forecast, by Model Types (2023-2030) 6.4.9.2. Taiwan Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 6.4.9.3. Taiwan Mice Model Market Size and Forecast, by Application (2023-2030) 6.4.10. Rest of Asia Pacific 6.4.10.1. Rest of Asia Pacific Mice Model Market Size and Forecast, by Model Types (2023-2030) 6.4.10.2. Rest of Asia Pacific Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 6.4.10.3. Rest of Asia Pacific Mice Model Market Size and Forecast, by Application (2023-2030) 7. Middle East and Africa Mice Model Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 7.1. Middle East and Africa Mice Model Market Size and Forecast, by Model Types (2023-2030) 7.2. Middle East and Africa Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 7.3. Middle East and Africa Mice Model Market Size and Forecast, by Application (2023-2030) 7.4. Middle East and Africa Mice Model Market Size and Forecast, by Country (2023-2030) 7.4.1. South Africa 7.4.1.1. South Africa Mice Model Market Size and Forecast, by Model Types (2023-2030) 7.4.1.2. South Africa Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 7.4.1.3. South Africa Mice Model Market Size and Forecast, by Application (2023-2030) 7.4.2. GCC 7.4.2.1. GCC Mice Model Market Size and Forecast, by Model Types (2023-2030) 7.4.2.2. GCC Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 7.4.2.3. GCC Mice Model Market Size and Forecast, by Application (2023-2030) 7.4.3. Nigeria 7.4.3.1. Nigeria Mice Model Market Size and Forecast, by Model Types (2023-2030) 7.4.3.2. Nigeria Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 7.4.3.3. Nigeria Mice Model Market Size and Forecast, by Application (2023-2030) 7.4.4. Rest of ME&A 7.4.4.1. Rest of ME&A Mice Model Market Size and Forecast, by Model Types (2023-2030) 7.4.4.2. Rest of ME&A Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 7.4.4.3. Rest of ME&A Mice Model Market Size and Forecast, by Application (2023-2030) 8. South America Mice Model Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 8.1. South America Mice Model Market Size and Forecast, by Model Types (2023-2030) 8.2. South America Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 8.3. South America Mice Model Market Size and Forecast, by Application(2023-2030) 8.4. South America Mice Model Market Size and Forecast, by Country (2023-2030) 8.4.1. Brazil 8.4.1.1. Brazil Mice Model Market Size and Forecast, by Model Types (2023-2030) 8.4.1.2. Brazil Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 8.4.1.3. Brazil Mice Model Market Size and Forecast, by Application (2023-2030) 8.4.2. Argentina 8.4.2.1. Argentina Mice Model Market Size and Forecast, by Model Types (2023-2030) 8.4.2.2. Argentina Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 8.4.2.3. Argentina Mice Model Market Size and Forecast, by Application (2023-2030) 8.4.3. Rest Of South America 8.4.3.1. Rest Of South America Mice Model Market Size and Forecast, by Model Types (2023-2030) 8.4.3.2. Rest Of South America Mice Model Market Size and Forecast, by Therapeutic Area (2023-2030) 8.4.3.3. Rest Of South America Mice Model Market Size and Forecast, by Application (2023-2030) 9. Global Mice Model Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Mice Model Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Laboratory Corporation of America Holdings (Burlington, North Carolina, USA) 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Charles River Laboratories International, Inc. (Wilmington, Massachusetts, USA) 10.3. The Jackson Laboratory (Bar Harbor, Maine, USA) 10.4. Taconic Biosciences, Inc. (Germantown, New York, USA) 10.5. Crown Biosciences (San Diego, California, USA) 10.6. TransCure bioServices (Montreal, Quebec, Canada) 10.7. Cyagen Biosciences (Canton, Massachusetts, USA) 10.8. The Andersons, Inc. (Maumee, Ohio, USA) 10.9. Allentown, LLC (Allentown, New Jersey, USA)) 10.10. Envigo (Huntingdon, Cambridgeshire, UK) [Previously known as Harlan Laboratories] 10.11. Janvier Labs (Yvonné, France) 10.12. Genoway (Lyon, France) 10.13. Ingenious Targeting Laboratory (Ghent, Belgium) 10.14. Trans Genic, Inc. (Fukuoka, Japan) 10.15. Harbour Antibodies Bv (Harbin, China) [Harbour Biomed subsidiary] 10.16. PolyGene (Beijing, China) 10.17. GVK BIO (Hyderabad, India) 10.18. Ozgene Pty Ltd. (Brisbane, Queensland, Australia) 11. Key Findings 12. Industry Recommendations 13. Mice Model Market: Research Methodology 14. Terms and Glossary